Alok K. Singh, PhD

Disclosure information not submitted.

Presentation(s):

• MP06-11: Magnitude of STING Signaling Determines Antitumor Outcomes, and CD8+ T Cell Memory by BCG-STING in Urothelial Tumors

  Friday, May 13, 2022
  8:45 AM – 10:00 AM

• PD53-11: Divergent Therapeutic Outcomes of STING Agonist ADU-S100 in Intratumoral and Intravesical Treatment Regimens in Syngeneic Murine MB49 and in the N-methyl-N-nitrosourea (MNU) Rat Model of Urothelial Carcinoma

  Monday, May 16, 2022
  8:40 AM – 8:50 AM